Arthur H Cohen

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi request reprint Distinguished Scientists Lecture Series. HIV-associated nephropathy
    A H Cohen
    Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Nephron 83:111-6. 1999
  2. doi request reprint Collagen Type III Glomerulopathies
    Arthur H Cohen
    Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Adv Chronic Kidney Dis 19:101-6. 2012
  3. pmc Association of histologic variants in FSGS clinical trial with presenting features and outcomes
    Vivette D D'Agati
    Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York, USA
    Clin J Am Soc Nephrol 8:399-406. 2013

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Distinguished Scientists Lecture Series. HIV-associated nephropathy
    A H Cohen
    Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Nephron 83:111-6. 1999
    ..Therapy with zidovudine, corticosteroids, or angiotensin-converting enzyme inhibitors has met with modest success; to date, protease inhibitors have not been assessed...
  2. doi request reprint Collagen Type III Glomerulopathies
    Arthur H Cohen
    Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Adv Chronic Kidney Dis 19:101-6. 2012
    ..Structural lesions are of collagen type III within glomerular basement membranes, different in distribution to collagenofibrotic glomerulopathy. The clinical course is variable...
  3. pmc Association of histologic variants in FSGS clinical trial with presenting features and outcomes
    Vivette D D'Agati
    Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York, USA
    Clin J Am Soc Nephrol 8:399-406. 2013
    ..The FSGS Clinical Trial provided a unique opportunity to study the clinical impact of histologic variants in a well defined prospective cohort with steroid-resistant primary FSGS...